Dr. Reddy’s Laboratories
Phone: +91 914049002900
| Type | Public |
|---|---|
| Traded as | NSE: DRREDDY BSE: 500124 NYSE: RDY NSE NIFTY 50 Constituent |
| ISIN | |
| Industry | Pharmaceuticals |
| Founded | 1984 (1984) |
| Founders | Anji Reddy |
| Headquarters | Hyderabad; Telangana, India |
| Area served | Worldwide |
| Key people | G. V. Prasad (Co-Chairman & MD) Kallam Satish Reddy (Chairman) Erez Israeli (CEO) |
| Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, Biologics |
| Revenue |  ₹17,460 crore (US$2.2 billion) (2020) |
| Operating income | ₹1,599 crore (US$200 million) (2020) |
| Net income | ₹1,950 crore (US$240 million) (2020) |
| Total assets | ₹23,156 crore (US$2.9 billion) (2020) |
| Total equity | ₹15,499 crore (US$1.9 billion) (2020) |
| Number of employees | 21,650 (March 2020) |
| Website | www.drreddys.com |
Ask any of the 20,000 employees at Dr. Reddy’s why they come to work every day, and you are bound to hear, because ‘Good Health Can’t Wait.’ These simple words describe the deep-rooted belief that drives us. Sometimes, the simplest words describe the most profound truths. 'Good Health’ is always our goal. We see medicines not just as molecules, but as means to help patients regain their health. As a leader in the pharmaceutical industry, we realize our unique role; we have the ethical and moral imperative to ensure good health can be delivered to those who need it, and to promote wellness among them. 'Can't Wait’ reflects our commitment to act with speed to find innovative solutions that address the unmet needs of patients, and to accelerate access to much-needed medicines for people around the world. Our belief is guided by our principles - Empathy and Dynamism - which provide both guidance for our current behaviour and inspiration for our future actions.
For detailed contact information visit location pages below.